BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

372 related articles for article (PubMed ID: 15791294)

  • 21. RNA interference inhibits respiratory syncytial virus replication and disease pathogenesis without inhibiting priming of the memory immune response.
    Zhang W; Tripp RA
    J Virol; 2008 Dec; 82(24):12221-31. PubMed ID: 18818323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intravenous palivizumab and ribavirin combination for respiratory syncytial virus disease in high-risk pediatric patients.
    Chávez-Bueno S; Mejías A; Merryman RA; Ahmad N; Jafri HS; Ramilo O
    Pediatr Infect Dis J; 2007 Dec; 26(12):1089-93. PubMed ID: 18043443
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of respiratory syncytial virus on the activity of matrix metalloproteinase in mice.
    Li W; Shen HH
    Chin Med J (Engl); 2007 Jan; 120(1):5-11. PubMed ID: 17254480
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pneumonia virus of mice infection model for severe respiratory syncytial virus infection: identifying novel targets for therapeutic intervention.
    Rosenberg HF; Bonville CA; Easton AJ; Domachowske JB
    Pharmacol Ther; 2005 Jan; 105(1):1-6. PubMed ID: 15626452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of cysteinyl leukotrienes in airway inflammation and responsiveness following RSV infection in BALB/c mice.
    Fullmer JJ; Khan AM; Elidemir O; Chiappetta C; Stark JM; Colasurdo GN
    Pediatr Allergy Immunol; 2005 Nov; 16(7):593-601. PubMed ID: 16238585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of airway eosinophil and neutrophil infiltration by alpha-galactosylceramide in a mouse model for respiratory syncytial virus (RSV) vaccine-augmented disease.
    Benoit AC; Huang Y; Maneewatchararangsri S; Tapchaisri P; Anderson R
    Vaccine; 2007 Nov; 25(45):7754-62. PubMed ID: 17920164
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients.
    Whimbey E; Champlin RE; Englund JA; Mirza NQ; Piedra PA; Goodrich JM; Przepiorka D; Luna MA; Morice RC; Neumann JL
    Bone Marrow Transplant; 1995 Sep; 16(3):393-9. PubMed ID: 8535312
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immune and functional role of nitric oxide in a mouse model of respiratory syncytial virus infection.
    Stark JM; Khan AM; Chiappetta CL; Xue H; Alcorn JL; Colasurdo GN
    J Infect Dis; 2005 Feb; 191(3):387-95. PubMed ID: 15633098
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age-related differences in pulmonary cytokine response to respiratory syncytial virus infection: modulation by anti-inflammatory and antiviral treatment.
    Boukhvalova MS; Yim KC; Kuhn KH; Hemming JP; Prince GA; Porter DD; Blanco JC
    J Infect Dis; 2007 Feb; 195(4):511-8. PubMed ID: 17230410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection.
    Stark JM; Stark MA; Colasurdo GN; LeVine AM
    J Med Virol; 2006 Jun; 78(6):829-38. PubMed ID: 16628585
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A multi-drug regimen for respiratory syncytial virus and parainfluenza virus infections in adult lung and heart-lung transplant recipients.
    Liu V; Dhillon GS; Weill D
    Transpl Infect Dis; 2010 Feb; 12(1):38-44. PubMed ID: 19761558
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DSCG reduces RSV-induced illness in RSV-infected mice.
    Hashimoto K; Mori S; Hashimoto Y; Kaneko H; Ishibashi K; Ishioka K; Kawasaki Y; Peebles RS; Munakata M; Hosoya M; Suzutani T
    J Med Virol; 2009 Feb; 81(2):354-61. PubMed ID: 19107959
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Leflunomide prevents alveolar fluid clearance inhibition by respiratory syncytial virus.
    Davis IC; Lazarowski ER; Hickman-Davis JM; Fortenberry JA; Chen FP; Zhao X; Sorscher E; Graves LM; Sullender WM; Matalon S
    Am J Respir Crit Care Med; 2006 Mar; 173(6):673-82. PubMed ID: 16387801
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.
    Dodd JS; Lum E; Goulding J; Muir R; Van Snick J; Openshaw PJ
    J Immunol; 2009 Dec; 183(11):7006-13. PubMed ID: 19915054
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of mucosal B-cell memory by intranasal immunization of mice with respiratory syncytial virus.
    Valosky J; Hishiki H; Zaoutis TE; Coffin SE
    Clin Diagn Lab Immunol; 2005 Jan; 12(1):171-9. PubMed ID: 15643003
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of interleukin-4 by recombinant respiratory syncytial virus is associated with accelerated inflammation and a nonfunctional cytotoxic T-lymphocyte response following primary infection but not following challenge with wild-type virus.
    Bukreyev A; Belyakov IM; Prince GA; Yim KC; Harris KK; Berzofsky JA; Collins PL
    J Virol; 2005 Aug; 79(15):9515-26. PubMed ID: 16014914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of cethromycin (ABT-773) therapy on microbiological, histologic, immunologic, and respiratory indices in a murine model of Mycoplasma pneumoniae lower respiratory infection.
    Ríos AM; Mejías A; Chávez-Bueno S; Fonseca-Aten M; Katz K; Hatfield J; Gómez AM; Jafri HS; McCracken GH; Ramilo O; Hardy RD
    Antimicrob Agents Chemother; 2004 Aug; 48(8):2897-904. PubMed ID: 15273098
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoprophylaxis and immunotherapy of respiratory syncytial virus-infected mice with respiratory syncytial virus-specific immune serum.
    Graham BS; Davis TH; Tang YW; Gruber WC
    Pediatr Res; 1993 Aug; 34(2):167-72. PubMed ID: 8233720
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
    Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
    J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.